Amgen (AMGN) sales are higher after early results from a study of an obesity drug. Renita Young discusses this as the Amgen CEO is “very encouraged” by the results of the obesity drug study. Tune in to find out more about the stock market today.
Morning Trade Live
03 May 2024
SHARE
Market On Close
06 Mar 2024
Market On Close
28 Mar 2024
Morning Trade Live
07 Mar 2024
The Watch List
05 Mar 2024
Morning Trade Live
15 Apr 2024
The Watch List
06 Mar 2024